The study was carried out with the financial
support of the Russian Foundation for Basic Research
within the framework of scientific project No. 18-29-
14073.
REFERENCES
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H. et al.,
2020. Genomic characterisation and epidemiology of
2019 novel coronavirus: implications for virus origins
and receptor binding. Lancet, 395.
Carvalho, T., Krammer, F., Iwasaki, A., 2021. The first 12
months of COVID-19: a timeline of immunological
insights. Nature Reviews Immunology, 21.
Richardson, S., Hirsch, J.S., Narisimhan, M., Crawford,
J.M., McGinn, T., Davidson, K.W. et al., 2020.
Presenting characteristics, comorbidities, and outcomes
among 5700 patients hospitalized with COVID-19 in
the New York City area. JAMA, 323.
Planas, D., Veyer, D., Baidaliuk, A., Baidaliuk, A.,
Staropoli, I., Guivel-Benhassine, F., Rajah, M.M. et al.,
2021. Reduced sensitivity of SARS-CoV-2 variant
Delta to antibody neutralization. Nature, 596.
Pouwels, K.B., House, T., Pritchard, E., Robotham, J.V.,
Birrell, P.J., Gelman, A. et al., 2021. Community
prevalence of SARS-CoV-2 in England from April to
November, 2020: results from the ONS Coronavirus
Infection Survey. Lancet Public Health, 6.
Nafilyan, V., Pawelek, P., Ayoubkhani, D., Rhodes, S.,
Pembrey, L., Matz, M. et al., 2021. Occupation and
COVID-19 mortality in England: a national linked data
study of 14.3 million adults, MedRxiv.
Burdorf, L., Porru, F., Rugulies, R., 2020. The Covid-19
(Coronavirus) pandemic: consequence for occupational
health. Scandinavian Journal of Work Environment and
Health, 46: 3.
Chadeau-Hyam, M., Bodinier, B., Elliott, J., Whitaker,
M.D., Tzoulaki, I., Vermeulen, R. et al., 2020. Risk
factors for positive and negative COVID-19 tests: A
cautious and in-depth analysis of UK biobank data,
International Journal of Epidemiology, 49: 5.
Sim, M.R., 2020. The COVID-19 pandemic: major risks to
healthcare and other workers on the front line.
Occupational and Environmental Medicine, 77: 5.
Mutambudzi, M., Niedzwiedz, C., Macdonald, E.B.,
Leyland, A., Mair, F,. Anderson, J. et al., 2021.
Occupation and risk of severe COVID-19: prospective
cohort study of 120 075 UK Biobank participants,
Occup. Environ. Med., 78: 5.
Denollet, J., De Potter, B., 1992. Coping subtypes for men
with coronary heart disease: relationship to well-being,
stress and Type-A behavior. Psychological Medicine,
22: 3.
Kucherenko, K.N., Belyakov, V.I., 2018. Analysis of the
adaptive potential of the circulatory system and
possible risks of cardiovascular pathology in the high
school students with coronary behavior A. Journal of
Clinical and Experimental Cardiology, 9.
Melentyev, I.A., Vershinin, A.A.. Kolesnikova, E.A.,
Melentyev, N.A. Malygina, I.V. Kostomarova, V.P.
Zaitse, A.S., 2006. Koronary heart disease clinical
course, post-infarction remodeling, psychological
status, and hospitalization time in patients with various
ACE genotypes. Russian Journal of Cardiology, 3.
Ruzanova, V.D., Belyakov, V.I., 2020. Problemy
legalizacii ispol'zovaniya geneticheskih tekhnologij i
dannyh cirkadiannoj fiziologii v sisteme
professional'nogo otbora. YUridicheskij vestnik
Samarskogo universiteta, 2.
Zheng, L., Wang, X., Zhou , C., Liu, Q., Li , S., Sun, Q. et
al., 2020. Analysis of the infection status of the health
care workers in Wuhan during the COVID-19 outbreak:
A cross-sectional study. Clinical Infectious Diseases,
71: 16.
Zhanq, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S. et al.,
2020. COVID-19: Melatonin as a potential adjuvant
treatment. Life Science, 250.
Debnath, М., Banerjee, М., Berk, М., 2020. Genetic
gateways to COVID-19 infection: Implications for risk,
severity, and outcomes. The FASEB Journal, 34: 7.
Anastassopoulou, C., Gkizarioti, Z., Patrinos, G.P., Tsakris,
A., 2020. Human genetic factors associated with
susceptibility to SARS-CoV-2 infection and COVID-
19 disease severity. Human Genomics, 14: 40.
Pathak, G.A., Singh, K., Miller-Fleming, T.W., Wendt,
F.R., Ehsan, N., Hou, K. et al., 2021. Integrative
genomic analyses identify susceptibility genes
underlying COVID-19 hospitalization. Nature
Communications, 12.
Pairo-Castineira, E., Clohisey, S., Klaric, L., Klaric, L.,
Bretherick, A.D., Rawlik, K., Pasko, D. et al., 2021.
Genetic mechanisms of critical illness in COVID-19.
Nature, 591.
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng,
Y., Wawrzyniak, P. et al., 2020. Distribution of ACE2,
CD147, CD26 and other SARS‐CoV‐2 associated
molecules in tissues and immune cells in health and in
asthma, COPD, obesity, hypertension, and COVID‐19
risk factors. Allergy, 75.
SHarapova, A.I., Antonova, N.L., 2020. Sovremennye
problemy upravleniya personalom v organizaciyah v
sfere zdravoohraneniya. Tendencii razvitiya nauki i
obrazovaniya, 62: 11.
Ruzanova, V.D., Belyakov, V.I., 2020. Problemy
legalizacii ispol'zovaniya geneticheskih tekhnologij i
dannyh cirkadiannoj fiziologii v sisteme
professional'nogo otbora. YUridicheskij vestnik
Samarskogo universiteta, 2.
Ruzanova, V.D., Inyushkin, A.A., Kryukova, E.S.,
Povarov, I.S., Belyakov, V.I., 2020. Legal and ethical
issues of genetic passportization, European journal of
human genetics 2020, 28: 1.
Manasyan, R.V., Sapozhnikova, N.I., 2021. Osobennosti
pravovogo regulirovaniya truda medicinskih
rabotnikov. Modern Science, 6: 2.